Holen Sie sich die Stockscreener-App
6.17
2.49%
0.15
Vorhandelsmarkt:
6.01
-0.16
-2.59%
Fennec Pharmaceuticals Inc Aktie (FENC) Neueste Nachrichten
Fennec Pharmaceuticals Hits Day Low of CAD 8.26 Amid Price Pressure - Markets Mojo
Day Trade: Will Fennec Pharmaceuticals Inc benefit from AI trendsEarnings Summary Report & Short-Term High Return Ideas - baoquankhu1.vn
Adherex Technologies (FENC) to Release Earnings on Wednesday - Defense World
Fennec Pharmaceuticals Reports Record 2025 PEDMARK® Sales Growth and Financial Results, Highlights Pipeline and Global Expansion - Minichart
(FENC) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Fennec Pharmaceuticals Reports Record FY2025 Net Product Sales of $44.6M, Q4 Sales $13.8M - TradingView
Record PEDMARK growth but wider 2025 loss for Fennec (NASDAQ: FENC) - Stock Titan
Fennec Pharmaceuticals Inc (FENC) Q4 2025 Earnings Call Highlights: Record Sales and Strategic ... By GuruFocus - Investing.com Canada
Fennec Pharmaceuticals misses Q4 estimates on earnings and revenue - MSN
Adherex Technologies Q4 2025 Earnings Call Transcript - MarketBeat
Earnings Call Summary | Fennec Pharmaceuticals(FENC.US) Q4 2025 Earnings Conference - Moomoo
Adherex Technologies Q4 Earnings Call Highlights - MarketBeat
Adherex Technologies (NASDAQ:FENC) Announces Earnings Results - MarketBeat
Earnings call transcript: Fennec Pharmaceuticals Q4 2025 misses expectations - Investing.com
Craig-Hallum Maintains Fennec Pharmaceuticals(FENC.US) With Buy Rating - Moomoo
Fennec Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Fennec Pharmaceuticals posts fiscal year 2025 financial results and business update - Traders Union
Fennec Pharmaceuticals Inc. (FENC) Misses Q4 EPS Estimates - AlphaStreet
Fennec Pharmaceuticals Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2025 - marketscreener.com
Fennec Pharmaceuticals (NASDAQ:FENC) Reports Q4 2025 Revenue Growth but Misses Earnings Estimates - ChartMill
Fennec Pharmaceuticals Posts Record PEDMARK Sales and Broadens Clinical Footprint in 2025 - TipRanks
FENNEC PHARMACEUTICALS ($FENC) Releases Q4 2025 Earnings - Quiver Quantitative
Fennec Pharmaceuticals misses Q4 estimates on earnings, revenue - Investing.com UK
Fennec Pharmaceuticals misses Q4 estimates on earnings, revenue By Investing.com - Investing.com South Africa
Fennec Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - The Manila Times
Cancer hearing-loss drug lifts Fennec sales 50% as debt hits zero - Stock Titan
Fennec Pharmaceuticals earnings are imminent; these most accurate analysts revise forecasts ahead of earnings call - MSN
Fennec Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Benzinga
FRX.CA Forecast, Price Target & Analyst Ratings | FENNEC PHARMACEUTICALS INC (TSX:FRX) - ChartMill
Fennec Pharmaceuticals (TSX:FRX) Shares Drift Below Key Average Level - Kalkine Media
Fennec Pharma (TSX:FRX) Falls Below Key Average in TSX Index - Kalkine Media
Fennec to Report 2025 Results as Global Rollout of PEDMARK Advances - The Globe and Mail
Fennec Pharmaceuticals (TSE:FRX) Shares Cross Below 50 Day Moving AverageTime to Sell? - MarketBeat
Retail Surge: Is Fennec Pharmaceuticals Inc still a buy after recent gains2026 Big Picture & Reliable Trade Execution Plans - baoquankhu1.vn
Breakout Zone: Can Fennec Pharmaceuticals Inc stock outperform in a bear marketTrend Reversal & Long-Term Capital Growth Ideas - baoquankhu1.vn
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2025 Financial Results on March 24, 2026 - The Manila Times
Fennec Pharmaceuticals Inc. - Mena FN
Fennec schedules March 24 call to unveil full-year 2025 numbers - Stock Titan
Cipla To Hold Off On Pediatric Cancer Drug Generic Until 2033 - Law360
B Riley Reaffirms Fennec's Buy Rating, US$16.00 Price Target After Cipla Settlement - marketscreener.com
Fennec settles patent case with Cipla over generic PEDMARK By Investing.com - Investing.com Australia
FENC Stock Quote - RichTv
Fennec Pharmaceuticals (FENC) delays Cipla generic PEDMARK rival until 2033 - Stock Titan
Fennec Pharmaceuticals announces settlement agreement resolving Pedmark patent litigation - marketscreener.com
Fennec settles patent case with Cipla over generic PEDMARK - Investing.com
Fennec Pharmaceuticals Announces Settlement Agreement Resolving Pedmark Patent Litigation - TradingView
Fennec Pharmaceuticals Announces Settlement Agreement Resolving PEDMARK Patent Litigation - The Manila Times
Patent deal delays PEDMARK generic, drug for chemo hearing loss, to 2033 - Stock Titan
(FRX) Technical Patterns and Signals (FRX:CA) - Stock Traders Daily
Adherex Technologies (NASDAQ:FENC) Cut to Buy at Wall Street Zen - MarketBeat
Liquidity Mapping Around (FENC) Price Events - Stock Traders Daily
(FRX) Market Insights and Trading Signals (FRX:CA) - Stock Traders Daily
FRX.CA Earnings History & Surprises | EPS & Revenue Results | FENNEC PHARMACEUTICALS INC (TSX:FRX) - ChartMill
Fennec Pharmaceuticals Hits Day Low of CAD 10.35 Amid Price Pressure - Markets Mojo
Adolescent cancer patients face unique survivorship hurdles, Fennec Pharmaceuticals asserts - Traders Union
Fennec Pharmaceuticals Hits Day Low of CAD 10.95 Amid Price Pressure - Markets Mojo
Fennec Pharmaceuticals Announces Clinical Research Collaboration With Tampa General Hospital Cancer Institute - Florida Hospital News and Healthcare Report
Adherex Technologies Inc. (NASDAQ:FENC) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Will Fennec Pharmaceuticals Inc. stock maintain growth story2025 Sector Review & Fast Exit and Entry Strategy Plans - Naître et grandir
Can Fennec Pharmaceuticals Inc sustain earnings growth2025 Bull vs Bear & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Fennec Pharmaceuticals (TSX:FRX) Moves Higher on Renewed Trading Focus - Kalkine Media
Aug Chart Watch: Does Fennec Pharmaceuticals Inc outperform in volatile marketsJuly 2025 Big Picture & Daily Volume Surge Signals - baoquankhu1.vn
Fennec Pharmaceuticals (TSE:FRX) Shares Cross Above 50-Day Moving AverageWhat's Next? - MarketBeat
Fennec Pharmaceuticals Inc expected to post earnings of 4 cents a shareEarnings Preview - TradingView
Earnings Preview: Gossamer Bio (GOSS) Q4 Earnings Expected to Decline - Finviz
Fennec, Tampa General launch real-world PEDMARK oncology study - TipRanks
1.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):